Amid plummeting sales of its COVID-19 vaccines, Pfizer acquired Seagen, a biotech company that makes drugs designed to use monoclonal antibodies to deliver anti-cancer agents…
Amid plummeting sales of its COVID-19 vaccines, Pfizer acquired Seagen, a biotech company that makes drugs designed to use monoclonal antibodies to deliver anti-cancer agents…